OPTIMIZATION OF ANTIBACTERIAL THERAPY FOR NONSPECIFIC VAGINITIS IN WOMEN OF REPRODUCTIVE AGE

  • O. D. Ryazanova SI “Zaporizhia Medical Academy of Post-Graduate Education Ministry of Health of Ukraine”
  • G. I. Reznichenko SI “Zaporizhia Medical Academy of Post-Graduate Education Ministry of Health of Ukraine”
Keywords: nonspecific vaginitis, aerobic vaginitis, bacterial vaginosis, antibacterial therapy

Abstract

Objective. To study the bacteriological composition and sensitivity of vaginal microflora and to optimize antibacterial therapy in women of reproductive age with aerobic vaginitis and bacterial vaginosis.

Methods. 160 women (100%) were examined, which were divided into 2 clinical groups with subgroups: the main group - 94 (58,8 %) patients with nonspecific vaginitis, who received treatment according to developed clinical diagnostic algorithms and schemes. The comparison group included 66 (41,2 %) patients with nonspecific vaginitis, who received treatment according to known protocols. Methods: general clinical examination, gynecological examination, microscopic study (microscopy of vaginal smears according to the Amsel, Nugent and Donders criteria), bacteriological seeding and determination of the microflora’s sensitivity to antibacterial drugs on the automatic microbiological analyzer “VITEK 2” (France), statistical.

Results. In women with AV the highest percentage of sensitivity of vaginal microflora was to moxifloxacin - 30,0 % and there were no resistant pathogens, in patients with BV – sensitivity to secnidazole was 86,3 %. After appropriate antibiotics were prescribed, a significant decrease was established in the main group of Escherichia coli (c2=7,23; P=0,008), Staphylococcus aureus (c2=3,87; P<0,049), Streptococcus agalactiae (c2=3,87; P<0,049) in AV, and a significant decrease of Gardnerella vaginalis (c2=28,20; P=0,001) і Atopobium vaginae (c2=3,87; P<0,049) in BV.

Conclusion. Establishing the type of causative bacteria, its sensitivity to antibiotics and the appointment of rational antibacterial therapy are likely to improve clinical effectiveness in the near and long terms, reduce frequency of recurrence of nonspecific vaginitis.

References

Javed A, Parvaiz F, Manzoor S. Bacterial vaginosis: An insight into the prevalence, alternative treatments regimen and it's associated resistance patterns. Microb Pathog. 2019; 127: 21-30. doi: 10.1016/j.micpath.2018.11.046.

Ma X, Wu M, Wang C, Li H, Fan A, Wang Y, et al. The pathogenesis of prevalent aerobic bacteria in aerobic vaginitis and adverse pregnancy outcomes: a narrative review. Reproductive Health [Internet]. 2022;19(1). Available from: doi:10.1186/s12978-021-01292-8.

Amabebe E, Anumba OC. The Vaginal Microenvironment: The Physiologic Role of Lactobacilli. Frontiers in Medicine [Internet]. 2018;5. Available from: doi:10.3389/fmed.2018.00181.

Li T, Liu Z, Li K, Bai H. Evaluation of the vaginal microbiome in clinical diagnosis and management of vaginal infectious diseases. Chinese Medical Journal [Internet]. 2019;132(9):1100-1103. Available from: doi:10.1097/cm9.0000000000000211.

De FS, Campisciano G, Zanotta N, Ricci G, Comar M. The Vaginal Community State Types Microbiome-Immune Network as Key Factor for Bacterial Vaginosis and Aerobic Vaginitis. Frontiers in Microbiology [Internet]. 2019;10. Available from: doi:10.3389/fmicb.2019.02451.

Onderdonk AB, Delaney ML, Fichorova RN. The Human Microbiome during Bacterial Vaginosis. Clinical Microbiology Reviews [Internet]. 2016;29(2):223-238. Available from: doi:10.1128/cmr.00075-15.

Kaambo E, Africa C, Chambuso R, Passmore JS. Vaginal Microbiomes Associated With Aerobic Vaginitis and Bacterial Vaginosis. Frontiers in Public Health [Internet]. 2018;6. Available from: doi:10.3389/fpubh.2018.00078.

Salinas AM, Osorio VG, Pacha-Herrera D, Vivanco JS, Trueba AF, Machado A. Vaginal microbiota evaluation and prevalence of key pathogens in ecuadorian women: an epidemiologic analysis. Scientific Reports [Internet]. 2020;10(1). Available from: doi:10.1038/s41598-020-74655-z.

Yalew GT, Muthupandian S, Hagos K, Negash L, Venkatraman G, Hagos YM, et al. Prevalence of bacterial vaginosis and aerobic vaginitis and their associated risk factors among pregnant women from northern Ethiopia: A cross-sectional study. PLOS ONE [Internet]. 2022;17(2):e0262692. Available from: doi:10.1371/journal.pone.0262692.

Wang C, Fan A, Li H, Yan Y, Qi W, Wang Y, et al. Vaginal bacterial profiles of aerobic vaginitis: a case–control study. Diagnostic Microbiology and Infectious Disease [Internet]. 2020;96(4):114981. Available from: doi:10.1016/j.diagmicrobio.2019.114981.

Sherrard J, Wilson J, Donders G, Mendling W, Jensen JS. 2018 European (IUSTI/WHO) International Union against sexually transmitted infections (IUSTI) World Health Organisation (WHO) guideline on the management of vaginal discharge. International Journal of STD & AIDS [Internet]. 2018;29(13):1258-1272. Available from: doi:10.1177/0956462418785451.

Coudray MS, Madhivanan P. Bacterial vaginosis—A brief synopsis of the literature. European Journal of Obstetrics & Gynecology and Reproductive Biology [Internet]. 2020;245:143-148. Available from: doi:10.1016/j.ejogrb.2019.12.035.

Qi W, Li H, Wang C, Li H, Zhang B, Dong M, et al. Recent Advances in Presentation, Diagnosis and Treatment for Mixed Vaginitis. Frontiers in Cellular and Infection Microbiology [Internet]. 2021;11. Available from: doi:10.3389/fcimb.2021.759795.

Published
2022-09-30
How to Cite
Ryazanova, O. D., & Reznichenko, G. I. (2022). OPTIMIZATION OF ANTIBACTERIAL THERAPY FOR NONSPECIFIC VAGINITIS IN WOMEN OF REPRODUCTIVE AGE. Modern Medical Technology, (3(54), 20-25. https://doi.org/10.34287/MMT.3(54).2022.4
Section
Original research